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Background: Serum and sputum eosinophil cationic protein (ECP)
levels are correlated with asthma disease severity.
Objective: To establish a diagnostic accuracy of ECP and lactate
dehydrogenase (LDH) in serum (indirectly) and sputum (directly) as
inflammatory markers in asthma.
Patients and Methods: In a cross sectional study, 76 asthmatic
patients with exacerbation were enrolled in the study. ECP was
determined using enzyme linked immuno-assay.
Results: Asthmatic patients compared with control subjects, had a
significant higher levels of ECP and LDH in sputum. Both sputum
and serum ECP and LDH were reduced significantly with pred-
nisolone treatment. FEV1 was inversely correlated with sputum
ECP, serum ECP, and sputum LDH. A significant positive correla-
tion was noted between sputum ECP and sputum LDH. Serum LDH
does not demonstrate any significant correlations with other vari-
ables. The area under receiver operating characteristic curve showed
that sputum ECP (0.92) was a significantly an accurate marker more
than serum ECP (0.81), sputum (0.80) LDH, and serum (0.65) LDH.
Furthermore, the area under curve was lower for serum ECP (0.81)
than that for sputum ECP (0.92). However, serum ECP (0.81) was
more accurate marker than serum LDH (0.65).
Conclusion: Serum and sputum ECP as eosinophilic inflammatory
markers are associated with poor asthma control. Sputum ECP and
LDH were significantly an accurate markers more than serum ECP
and LDH.
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Previous studies have demonstrated that airway inflamma-tion in bronchial asthma directly by bronchoscopic biop-
sies, BAL, or sputum examinations1 or indirectly by mea-
surements of biomarkers in peripheral blood.2 The increase in
blood eosinophils and serum eosinophil cationic protein
(ECP) may be useful, indirect marker of airway inflammation
in asthma.3 Pizzichini et al4 reported that proportion of
eosinophils in sputum is a more accurate marker of asthmatic
airway inflammation than the proportion of blood eosinophils
or serum ECP. Recently, Jang et al5 reported that the propor-
tion of eosinophils in sputum have more accurate diagnostic
markers of asthmatic airway inflammation than NO metabo-
lites in sputum and blood in differentiating asthmatic patients
from control subjects. However, all the reported studies deal
with 1 to 3 parameters; this is the first study that evaluates
ECP and lactate dehydrogenase (LDH) in blood versus spu-
tum for the same patients. In the present study a comparative
investigation of airway inflammation directly (sputum) and
indirectly (serum) in asthma to establish diagnostic accuracy
of ECP and LDH in serum and sputum was performed.
MATERIALS AND METHOD
Patients
The subjects included in the study were outpatients
from the Asthma and Allergy Center and Samara General
Hospital outpatients Clinic. The diagnosis of asthma was
performed by a specialist physician and was established
according to the National Heart Blood and Lung Institute/
World Health Organization (NHBLI/WHO) workshop on the
Global Strategy for Asthma.6 Patients were excluded if they
were smokers, if they had respiratory infection within the
month preceding the study, a rheumatological illness, malig-
nancy, diabetic, heart failure, history of venous embolisms,
coronary heart disease, and liver or kidney diseases.
At enrolment, they all underwent full clinical examina-
tion, pulmonary function test, and blood sampling. Sputum
samples were collected from patients when indicated. Normal
volunteers were also enrolled in the study as a healthy
control. None of them had any previous history of lung or
allergic disease and were not using any medication. They had
a normal lung function test (FEV1 80%) and negative skin
allergy test. General stool examination was performed for all
patients and control to exclude parasitic infections.
The sampling performed during the period from May
2004 to January 2007. All samples were collected at morning
after an overnight fasting. A comparative investigation of
airway inflammation directly (sputum) and indirectly (serum)
in asthma to establish diagnostic accuracy of ECP and LDH
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in serum and sputum was performed. In a cross sectional
study, 95 asthmatic patients (exacerbation) were enrolled in
the study and only 76 of them completed the study. After
entry to the study, all patients receive oral prednisolone 30
mg for 7 days, followed by reduction of 5 mg/d up to zero.
Venous blood and sputum samples were collected at the time
of entry to the study and after 2 weeks of treatment course for
determination of sputum and serum ECP and LDH. The study
was approved by the ethics committee of our college, and
written consent was obtained from all participating subjects.
Skin Prick Test
The skin prick tests were performed and evaluated in
accordance with European Academy of Allergy and Clinical
Immunology subcommittee on allergy standardization and
skin tests using standard allergen panel (Stallergen, France).
The panel included the common inhalant allergens.
Sputum Collection
Sputum was induced only when it could not be pro-
duced spontaneously. Sputum induction was performed as
described by Fahy et al.7
Determination of Serum ECP
Serum ECP was determined by ELISA kit (MBL
MESCACUP ECP TEST) from Medical and Biologic Lab-
oratories Co, LTD, Japan. The test was performed accord-
ing to the instruction of manufacturer.
Determination of LDH
LDH activity was measured in serum or sputum super-
natant by an enzymatic rate method using pyruvate as sub-
strate. The test was performed using a colorimetric method
kit (Randox, UK) and the test it was performed according to
instruction of the manufacturer.
Statistical Analysis
The values are reported as mean SD and 95% CI. For
statistical analysis between groups paired t test was used.
Pearson test was used for correlation analysis. The diag-
nostic accuracy of sputum ECP, serum ECP, sputum LDH,
and serum LDH were determined by generating a receiver
operating characteristic (ROC) curve for each test. The levels
of each marker were compared between the study groups and
control group, using SPSS computer package. P values of
0.05 were considered significant.
RESULTS
Asthmatic patients compared with control subjects, had
significantly higher levels of ECP (Asthma, 751.8 g/l;
Control, 136.5 g/l, P  0.0001) and LDH (Asthma, 757.3
IU/l; Control, 25 IU/l, P  0.0001) in sputum. Furthermore,
serum ECP was significantly higher in asthmatic patients
(46.1 g/l) than in control (7.68 g/l; P  0.0001). In
addition, serum LDH was significantly higher in asthmatic
(453.9 IU/l) than in control subjects (126.3 IU/l, P  0.0001)
(Table 1).
After treatment with prednisolone at dose of 30 mg/d
for 7 days, followed by reduction of 5 mg/d up to zero. The
sputum ECP was reduced significantly (P  0.0001) from
751.8 g/l before treatment to 313 g/l after treatment.
Furthermore, prednisolone reduced sputum LDH signifi-
cantly from 757.3 IU/l before treatment to 276.8 IU/l after
treatment. Serum ECP level was reduced significantly
(P  0.0001) from 46.1 g/l before treatment to 16.42
TABLE 1. Markers of Airway Inflammation in Asthma:
Sputum Versus Blood
Sample Group Variable ECP g/l LDH IU/l
Sputum Asthma 76 Mean 751.80 757.3
SD 126.90 147.5
95% CI 697.6–808 694.4–831.89
Control 50 Mean 136.50 25
SD 42.2 5.7
95% CI 119.2–153.96 22.65–27.35
P value  0.0001 0.0001
Serum Asthma 76 Mean 46.1 453.9
SD 16.3 153.4
95% CI 38.28–53.82 377.06–545.54
Control 50 Mean 7.68 126.3
SD 5.63 57.2
95% CI 6.08–9.68 110.04–142.56
P value  0.0001 0.0001
TABLE 2. Effect of Prednisolone on Airway Inflammation Markers Concentrations in Sputum and Serum of Asthmatic
Patients
Variable ECP Mean g/l SD LDH Mean IU/l SD
Eosinophil Count ECP/EO Count
Mean SD Mean SD
Sputum
Pretreatment 751.8 126.9 757.32 147.5 0.41 0.25 1833 54
Posttreatment 313.0 119.8 276.8 82.1 0.23 0.34 1490 31
P value  0.0001 0.0001 0.001 0.0001
Serum
Pretreatment 46.1 16.3 453.9 153.4 479 174 0.096 0.043
Posttreatment 15.43 6.3 219.6 50.4 319 121 0.048 0.029
P value  0.0001 0.0001 0.0001 0.0001
ECP, eosinophil cationic protein; LDH, lactate dehydrogenase; EO, eosinophil.
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g/l after treatment. In addition, serum LDH was reduced
significantly (P  0.0001) from 453.9 IU/l to 219.9 IU/l
after treatment (Table 2).
Baseline sputum and serum values for ECP and LDH
were significantly (P  0.0001) higher than that for control
subjects. However, the posttreatment values for serum and
sputum values for all were still significantly higher than that
of control. Thus, sputum and serum inflammatory markers
were lower in normal subjects than in both untreated and
treated patients.
The eosinophil counts and ECP/Eosinophil counts ratio
were significantly in posttreatment as compared with baseline
values for sputum and blood samples. These findings may
suggest that determination of sputum ECP, LDH, Eosinophils
count, and ECP/Eosinophil count ratio were with diagnostic
accuracy for asthma as noninvasive markers.
The diagnostic accuracy of sputum and serum ECP and
LDH was determined by ROC curve (Figs. 1–4). The area
under ROC curve showed that sputum ECP (0.92) was
significantly an accurate marker more than serum ECP (0.83),
sputum LDH (0.80), and serum LDH (0.65). Furthermore,
serum ECP with lower area under curve (0.83) than sputum
ECP (0.92), however, serum ECP (0.83) was more an accu-
rate marker than serum LDH (0.65).
FIGURE 1. ROC sputum ECP in asthmatic patients.
FIGURE 2. ROC serum ECP in asthmatic patients.
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DISCUSSION
In the present study sputum ECP and LDH were sig-
nificantly increased in asthmatic patients as compared with
control subjects. Furthermore, serum ECP and LDH were
significantly higher in asthmatic than in controls subjects.
This contributes that both (sputum and serum) can be used as
direct and indirect markers of airway inflammation for spu-
tum and serum ECP, respectively.
Holz et al8 reported that sputum LDH was detected in
asthmatic patients with high levels. Furthermore, Wark et al9
reported that sputum LDH is elevated in acute asthma and it
was as a marker of cell necrosis in asthma. An increase in
airway LDH might arise from diverse sources, including: (a)
rupture (necrosis) of airway and/or alveolar epithelial cells,
alveolar macrophages, or other pulmonary cell types; (b)
increased influx of plasma derived LDH through an air/blood
barrier render more permeable by pulmonary injury (eg,
edema); and (c) elevated plasma LDH concentration resulting
in an increased rate of passage of LDH across the air/blood
barrier of a normal lung.10 Necrosis of epithelial cells and
granulocytes lead to the release of intracellular contents that
may themselves be proinflammatory.11 One of these products
is LDH that has been used to measure the extent of cell
lyses.12 Thus, LDH may serve as indicator suggestive of
disturbances of the cellular integrity induced by pathologic
changes in asthma.
FIGURE 3. ROC serum LDH in asthmatic patients.
FIGURE 4. ROC sputum LDH in asthmatic patients.
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This is the first report that evaluates the LDH activity in
sputum-versus-serum of asthmatic patients with comparison
to healthy subjects. The levels of LDH were significantly
higher in asthmatic than in control for both serum and sputum
LDH. However, the magnitude of increase as compared with
control was 30 times for sputum LDH, whereas it was around
4 times for serum. This may be a result of cell damage that
leads to extracellular appearance of the LDH12 and it may be
more in the airway than in the blood.
In acute asthma there was an intense sputum Neutrophil
influx and degranulation along with elevated ECP as this
study indicated. Sputum neutrophils were associated with
increased cell lyses measured by sputum LDH and increased
sputum LDH and ECP were associated with a longer hospital
stay.9 The majority of asthma exacerbation is to be associated
with viral respiratory tract infection.13 Respiratory viruses
infect bronchial epithelial cells, resulting in epithelial activa-
tion and increased Neutrophil recruitment and activation.14 In
addition, viral infection can cause extensive epithelial necro-
sis that is enhanced by neutrophils.15 The high prevalence of
viral infection in acute asthma was reported by different
studies.9,13
Wark’s study9 demonstrated that the mechanisms of
virus induced exacerbation differ from those of noninfective
acute asthma with increased neutrophilic inflammation. Those
with infection had an intense Neutrophil infiltrate and degranu-
lation that was not seen in noninfectious asthma. However,
sputum ECP was elevated to a similar degree in both groups.
Based on our results and that reported by Wark et al, it was
suggested that sputum LDH was a good marker of asthma
exacerbation and may be used to differentiate between infec-
tive and noninfective asthma. In fact, it is because of a
widespread distribution of LDH in the body, serum LDH was
abnormal in a host of disorders. It is released into the
peripheral blood after cell death caused by, for example,
ischemia, excess heat or cold, starvation, dehydration, injury,
and exposure to bacterial toxins. Therefore, the total serum
LDH is a highly sensitive but not specific test.12 Furthermore,
serum LDH is abnormal in a large number of disorders, its
sputum level may be a noninvasive marker that differentiates
asthmatics from normal subjects.
In the present study, the area under ROC curve showed
that sputum ECP was significantly an accurate marker more
than sputum LDH and serum ECP. Thus, ECP and LDH
determination in sputum was significantly an accurate marker
than their level in serum. Pizzichini et al4 reported that the
area under the ROC curve showed that sputum ECP was more
sensitive than serum ECP in differentiation of patients with
asthma from non asthmatic.
It is universally agreed that corticosteroids are the most
effective asthma therapy that suppresses inflammation in
asthmatic airways and they inhibit almost every aspect of the
inflammatory process.16 The serum ECP levels are high in
asthma; however, they are affected by the administration of
corticosteroids and decreased ahead of clinical improvement
of asthma attacks.17 Although, the sputum ECP was de-
creased concomitantly with clinical symptoms irrespective of
the administration of corticosteroids.18 Recently, Curric et
al19 reported that there was a significant reduction of sputum
but not serum ECP that is in keeping with previous work that
failed to show suppression after inhaled budesonide.20 Fur-
thermore, it may be considered that systemic indices of
asthma control are more distinct indirect markers of inflam-
matory activity occurring predominantly in the bronchial
mucosa.20 In the present study ECP levels in sputum and
serum were reduced significantly after treatment, this finding
is consistent with that reported by Jang et al21 concerning
sputum ECP.
In fact, steroids cause inhibition of epithelial NO pro-
duction, thus increasing the proliferation of TH1 cells, which
produce interferon gamma. This in turn acts on TH2 cells to
suppress the production of interleukin (IL)-4 and IL-5.16
Administration of oral prednisolone (30 mg/d) resulted in a
fall of LDH and ECP in both serum and sputum. Basically,
antiasthmatic drug treatment, including corticosteroids can
attenuate inflammatory reaction by down-regulating the re-
lease of IL-5 and by falling NO metabolites and by suppres-
sion of eosinophil activity.21 In the present study, LDH and
ECP in sputum and serum were higher at baseline and
declined significantly after prednisolone therapy, although
the levels were still higher as compared with controls. These
findings may reflect persistence of low levels of airway
inflammation despite control of symptoms.
The usefulness and safety of the analysis of blood
inflammatory markers in asthma are widely recognized. Re-
cently, the analysis of induced sputum has been proposed as
a safe, noninvasive tool in the study of airway inflammation
in asthma. This study is conducted to test whether sputum
analysis is more useful than blood analysis in the evaluation
of airway inflammation in asthmatic patients. Thus, our
findings suggest that examination of sputum can be used
successfully to speculate airway inflammation noninvasively
and to follow the effect (monitoring) of antiasthma treatment
in stable and exacerbation asthma. Furthermore, this study
indicated that sputum ECP, LDH, Eosinophil count, and
ECP/Eosinophil count may be with predictive value to dif-
ferentiate between stable and exacerbated asthma.
Airway inflammation has been considered as the
primary cause to airway obstruction and hyperresponsive-
ness.22 The investigations into the mechanisms involved in
the pathogenesis of asthma has been hampered by diffi-
culties in gaining direct access to asthmatic airway for
evaluating the inflammatory process. Until recently, it has not
been possible in clinical practice to measure inflammation
directly, and the presence or absence of airway inflammation
has been assumed from symptoms, measurement of bron-
chial hyperresponsiveness (BHR) and the effect of treat-
ment. Whereas, serum markers such as eosinophil count,
ECP, NO metabolites were indirect measures of inflam-
mation in asthma.23 The introduction of a method of
sputum analysis24 that is a noninvasive safe tool for anal-
ysis, the cellular and biochemical components of the air-
way secretions has allowed the direct measurement of
airway inflammation in asthma.7,24–27 In fact, measurement
of induced sputum has been shown to be a repeatable,
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valid, and feasible method for assessing eosinophilic air-
way inflammation.4,7,24,25,28
Increased LDH activity at presentation with acute
asthma was associated with more severe clinical disease. In
fact, increased LDH activity, along with elevated sputum
ECP are important predictors of more severe and protracted
acute asthma.9 It may also reflect a type of airway inflamma-
tion less responsive to corticosteroids. This indicates a po-
tential role for sputum LDH measurement to predict clinical
course in acute asthma.
The limitation of this study is the small-scale study
population, which make the generalization of the finding is
difficult. However, these study findings may encourage per-
forming a large-scale comparative study between serum and
sputum ECP and LDH.
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